Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Heim S, Mitelman F (eds): Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, 3rd edn. New York: Wiley-Blackwell.
European Cytogenetic Guidelines: ECA Newsletter, January 2012. Available at: http://e-c-a.eu/files/downloads/E.C.A._General_Guidelines_Version%202.0.pdf last accessed 16 January 2015.
ISO 15189:2012 Medical laboratories—Requirements for quality and competence.
Claustres M, Kožich V, Dequeker E et alon behalf of the ESHG Quality committee: Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic) (2013). Eur J Hum Genet 2013; 22: 160–170.
Shaffer LG, McGowan-Jordan J, Schmid M : ISCN 2013: An International System for Human Cytogenetic Nomenclature. Basel: S Karger, 2013.
European co-operation for accreditation: Available at: http://www.european-accreditation.org/ last accessed 16 January 2015.
UK NEQAS Executive Office: Sheffield S10 2PB. Available at: http://www.ukneqas.org.uk/ last accessed 16 January 2015.
Krijgsman O, Israeli D, Haan JC et al: CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material. Genes Chromosomes Cancer 2012; 51: 344–352.
Sie D, Snijders PJ, Meijer GA et al: Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology. Cell Oncol (Dordr) 2014; 37: 353–361.
Tuononen K, Mäki-Nevala S, Sarhadi VK et al: Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. Genes Chromosomes Cancer 2013; 52: 503–511.
The Royal College of Pathologists: The Retention and Storage of Pathological Records and Archives. London: The Royal College of Pathologists, 2006.
Peiró G, D Mayr D, Hillemanns P et al: Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome. Mod Pathol 2004; 17: 277–287.
Van Loo P, Nilsen G, Nordgard SH et al: Analyzing cancer samples with SNP arrays. Methods Mol Biol 2012; 802: 57–72.
Krijgsman O, Carvalho B, Meijer GA, Steenbergen RD, Ylstra B : Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack. Biochim Biophys Acta 2014; 1843: 2698–2704.
Krijgsman O, Israeli D, van Essen HF et al: Detection limits of DNA copy number alterations in heterogeneous cell populations. Cell Oncol (Dordr) 2013; 36: 27–36.
McGranahan N, Swanton C : Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 2015; 27: 15–26.
de Vree PJ, de Wit E, Yilmaz M et al: Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat Biotechnol 2014; 32: 1019–1025.
Watson IR, Takahashi K, Futreal PA, Chin L : Emerging patterns of somatic mutations in cancer. Nat Rev Genet 2013; 14: 703–718.
Scheinin I, Sie D, Bengtsson H et al: DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res 2014; 24: 2022–2032.
Ding L, Wendl MC, McMichael JF, Raphael BJ : Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet 2014; 15: 556–570.
Rigter T, Henneman L, Kristoffersson U et al: Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics. Hum Mutat 2013; 34: 1322–1328.
Ulahannan D, Kovac MB, Mulholland PJ, Cazier J-B, Tomlinson I : Technical and implementation issues in using next-generation sequencing of cancers in clinical practice. Br J Cancer 2013; 109: 827–835.
Tripathy D, Harnden K, Kimberly Blackwell K, Robson M : Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic? BMC Med 2014; 12: 140 http://www.biomedcentral.com/1741-7015/12/140/—ins1.
Ambros PF, Ambros IM, Brodeur GM et al: International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009; 100: 1471–1482.
Walker RA, Bartlett JM, Dowsett M, Ellis IO et al: HER2 testing in the UK: further update to recommendations. J Clin Pathol 2008; 61: 818–824.
Wolff AC, Hammond MEH, Hicks DG et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol 2013; 31: 3997–4014.
Acknowledgements
We wish to acknowledge feedback from Barbara Dewaele, Belinda Carleer, Jérome Couturier, Vanessa Vanspauwen, and other colleagues in their departments on these guidelines. We would also like to acknowledge the contribution of Alain Bernheim who sadly passed away before the publication of these guidelines. These guidelines resulted from a Tumour Best Practice meeting held on 23rd April 2013 in Oxford that that was funded by Eurogentest (FP7- HEALTH-F4-2010-261469). We thank Cheryl Guiver for her help in the organisation of the Best Practice meeting.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Hastings, R., Bown, N., Tibiletti, M. et al. Guidelines for cytogenetic investigations in tumours. Eur J Hum Genet 24, 6–13 (2016). https://doi.org/10.1038/ejhg.2015.35
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2015.35
This article is cited by
-
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
Nature Communications (2021)
-
A novel next generation sequencing approach to improve sarcoma diagnosis
Modern Pathology (2020)
-
Use of uracil-DNA glycosylase enzyme to reduce DNA-related artifacts from formalin-fixed and paraffin-embedded tissues in diagnostic routine
Applied Cancer Research (2019)
-
HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
Scientific Reports (2019)
-
c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers
Virchows Archiv (2018)
